Published online before print March 26, 2007, doi: 10.1161/CIRCULATIONAHA.106.653568
(Circulation. 2007;115:2006-2014.)
© 2007 American Heart Association, Inc.
Imaging |
Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction
From the Division of Cardiology, Department of Medicine (A.S., C.F.A., A.C., D.A.B., G.G., R.G.W., E.M., G.F.T., J.A.C.L., K.C.W.) and Department of Radiology (D.A.B., R.G.W., J.A.C.L.), Johns Hopkins University; and the Applied Science Laboratory, GE Healthcare Technologies (S.N.G., T.K.F.), Baltimore, Md.
Reprint requests to Katherine C. Wu, MD, Division of Cardiology, Johns Hopkins Hospital, 600 N Wolfe St, Carnegie 568, Baltimore, MD 21287. E-mail kwu{at}jhmi.edu
Received April 29, 2005; accepted February 20, 2007.
Background— The extent of the peri-infarct zone by magnetic resonance imaging (MRI) has been related to all-cause mortality in patients with coronary artery disease. This relationship may result from arrhythmogenesis in the infarct border. However, the relationship between tissue heterogeneity in the infarct periphery and arrhythmic substrate has not been investigated. In the present study, we quantify myocardial infarct heterogeneity by contrast-enhanced MRI and relate it to an electrophysiological marker of arrhythmic substrate in patients with left ventricular (LV) systolic dysfunction undergoing prophylactic implantable cardioverter defibrillator placement.
Methods and Results— Before implantable cardioverter defibrillator implantation for primary prevention of sudden cardiac death, 47 patients underwent cine and contrast-enhanced MRI to measure LV function, volumes, mass, and infarct size. A method for quantifying the heterogeneous infarct periphery and the denser infarct core is described. MRI indices were related to inducibility of sustained monomorphic ventricular tachycardia during electrophysiological or device testing. For the noninducible versus inducible patients, LV ejection fraction (30±10% versus 29±7%, P=0.79), LV end-diastolic volume (220±70 versus 228±57 mL, P=0.68), and infarct size by standard contrast-enhanced MRI definitions (P=NS) were similar. Quantification of tissue heterogeneity at the infarct periphery was strongly associated with inducibility for monomorphic ventricular tachycardia (noninducible versus inducible: 13±9 versus 19±8 g, P=0.015) and was the single significant factor in a stepwise logistic regression.
Conclusions— Tissue heterogeneity is present and quantifiable within human infarcts. More extensive tissue heterogeneity correlates with increased ventricular irritability by programmed electrical stimulation. These findings support the hypothesis that anatomic tissue heterogeneity increases susceptibility to ventricular arrhythmias in patients with prior myocardial infarction and LV dysfunction.
CLINICAL PERSPECTIVE
Related Article:
-
Issue Highlights
Circulation 2007 115: 1969.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  S. Kelle, S. D. Roes, C. Klein, T. Kokocinski, A. de Roos, E. Fleck, J. J. Bax, and E. Nagel Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1770 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1407 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Goldfarb, M. Roth, and J. Han Myocardial Fat Deposition after Left Ventricular Myocardial Infarction: Assessment by Using MR Water-Fat Separation Imaging Radiology, October 1, 2009; 253(1): 65 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Myerburg, V. Reddy, and A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Knecht, F. Sacher, M. Wright, M. Hocini, A. Nogami, T. Arentz, B. Petit, R. Franck, C. De Chillou, D. Lamaison, et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J. Am. Coll. Cardiol., August 4, 2009; 54(6): 522 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. Kwong and M. A. Pfeffer Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling? Eur. Heart J., June 2, 2009; 30(12): 1431 - 1433. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Menasche Stem Cell Therapy for Heart Failure: Are Arrhythmias a Real Safety Concern? Circulation, May 26, 2009; 119(20): 2735 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Whyte, R. Godfrey, R. O'Hanlon, M. Wilson, J. Buckley, and S. Sharma Acute myocardial infarction in the presence of normal coronaries and the absence of risk factors in a young, lifelong regular exerciser BMJ Case Reports, May 25, 2009; 2009(may25_1): bcr0720080384 - bcr0720080384. [Abstract] [Full Text]
|
|
|
|
|
|
K. H. Schuleri, M. Centola, R. T. George, L. C. Amado, K. S. Evers, K. Kitagawa, A. L. Vavere, R. Evers, J. M. Hare, C. Cox, et al. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1699 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon The Prognostic Implications of Cardiovascular Magnetic Resonance Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Roes, C. J. W. Borleffs, R. J. van der Geest, J. J.M. Westenberg, N. A. Marsan, T. A.M. Kaandorp, J. H.C. Reiber, K. Zeppenfeld, H. J. Lamb, A. de Roos, et al. Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator Circ Cardiovasc Imaging, May 1, 2009; 2(3): 183 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vigmond, F. Vadakkumpadan, V. Gurev, H. Arevalo, M. Deo, G. Plank, and N. Trayanova Towards predictive modelling of the electrophysiology of the heart Exp Physiol, May 1, 2009; 94(5): 563 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Bottomley, K. C. Wu, G. Gerstenblith, S. P. Schulman, A. Steinberg, and R. G. Weiss Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study Circulation, April 14, 2009; 119(14): 1918 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Oakes, T. J. Badger, E. G. Kholmovski, N. Akoum, N. S. Burgon, E. N. Fish, J. J.E. Blauer, S. N. Rao, E. V.R. DiBella, N. M. Segerson, et al. Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation Circulation, April 7, 2009; 119(13): 1758 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Meyer, M. M. LeWinter, S. P. Bell, Z. Chen, D. E. Selby, D. K. Singla, and H. L. Dauerman N-Acetylcysteine-Enhanced Contrast Provides Cardiorenal Protection J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 215 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wu Fighting the "Fire" of Myocardial Reperfusion Injury: How to Define Success? J. Am. Coll. Cardiol., February 24, 2009; 53(8): 730 - 731. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nazarian, D. A. Bluemke, and H. R. Halperin Applications of Cardiac Magnetic Resonance in Electrophysiology Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 63 - 71. [Full Text] [PDF]
|
|
|
|
|
|
H. Engblom, E. Hedstrom, E. Heiberg, G. S. Wagner, O. Pahlm, and H. Arheden Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction Zone: One-Year Follow-Up by MRI Circ Cardiovasc Imaging, January 1, 2009; 2(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Strauss, R. H. Selvester, J. A.C. Lima, H. Arheden, J. M. Miller, G. Gerstenblith, E. Marban, R. G. Weiss, G. F. Tomaselli, G. S. Wagner, et al. ECG Quantification of Myocardial Scar in Cardiomyopathy Patients With or Without Conduction Defects: Correlation With Cardiac Magnetic Resonance and Arrhythmogenesis Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Myerburg Implantable Cardioverter-Defibrillators after Myocardial Infarction N. Engl. J. Med., November 20, 2008; 359(21): 2245 - 2253. [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Leaf, J. E. Feig, C. Vasquez, P. L. Riva, C. Yu, J. M. Lader, A. Kontogeorgis, E. L. Baron, N. S. Peters, E. A. Fisher, et al. Connexin40 Imparts Conduction Heterogeneity to Atrial Tissue Circ. Res., October 24, 2008; 103(9): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Bilchick, V. Dimaano, K. C. Wu, R. H. Helm, R. G. Weiss, J. A. Lima, R. D. Berger, G. F. Tomaselli, D. A. Bluemke, H. R. Halperin, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. J. Am. Coll. Cardiol. Img., September 1, 2008; 1(5): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dall'Armellina, T. M. Morgan, S. Mandapaka, W. Ntim, J. J. Carr, C. A. Hamilton, J. Hoyle, H. Clark, P. Clark, K. M. Link, et al. Prediction of Cardiac Events in Patients With Reduced Left Ventricular Ejection Fraction With Dobutamine Cardiovascular Magnetic Resonance Assessment of Wall Motion Score Index J. Am. Coll. Cardiol., July 22, 2008; 52(4): 279 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wu, R. G. Weiss, D. R. Thiemann, K. Kitagawa, A. Schmidt, D. Dalal, S. Lai, D. A. Bluemke, G. Gerstenblith, E. Marban, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2414 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bogun, B. Desjardins, T. Crawford, E. Good, K. Jongnarangsin, H. Oral, A. Chugh, F. Pelosi, and F. Morady Post-Infarction Ventricular Arrhythmias Originating in Papillary Muscles J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1794 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nazarian and J. A.C. Lima Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1375 - 1376. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Goldberger Letter Regarding Article by Schmidt et al, "Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction" Circulation, November 13, 2007; 116(20): e536 - e536. [Full Text] [PDF]
|
|
|
|
|
|
H. Ashikaga, T. Sasano, J. Dong, M. M. Zviman, R. Evers, B. Hopenfeld, V. Castro, R. H. Helm, T. Dickfeld, S. Nazarian, et al. Magnetic Resonance Based Anatomical Analysis of Scar-Related Ventricular Tachycardia: Implications for Catheter Ablation Circ. Res., October 26, 2007; 101(9): 939 - 947. [Abstract] [Full Text] [PDF]
|
|